Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weber

Showing results (1121-1130 of 1,217) with videos related to

Pageof 122
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patientsYu Zhao, Ran Zhou, Bingqing Xie, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2025
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescencePujan Engels, Andras Szolek, Sebastian Hörner, et al.
Nature Communications|January 9, 2020
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasisFranziska Herster, Zsofia Bittner, Nathan K Archer, et al.
Mabs|April 4, 2022
In silico proof of principle of machine learning-based antibody design at unconstrained scaleRahmad Akbar, Philippe A Robert, Cédric R Weber, et al.
Biomedicines|September 23, 2022
<i>TLR5</i> Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell LineJurica Baranašić, Maja Šutić, Calogerina Catalano, et al.
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Annals of Hepatology|December 3, 2015
Hypothermia is better than ischemic preconditioning for preventing early hepatic ischemia/reperfusion in ratsLarisse Longo, Leila Xavier Sinigaglia-Fratta, Giovana R Weber, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Vaccines|September 28, 2023
CD4<sup>+</sup> T Cell Responses to <i>Toxoplasma gondii</i> Are a Double-Edged SwordKamal El Bissati, Paulette A Krishack, Ying Zhou, et al.
Pageof 122

Showing results (1121-1130 of 1,217) with videos related to

Sort By:
Pageof 122
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patientsYu Zhao, Ran Zhou, Bingqing Xie, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2025
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescencePujan Engels, Andras Szolek, Sebastian Hörner, et al.
Nature Communications|January 9, 2020
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasisFranziska Herster, Zsofia Bittner, Nathan K Archer, et al.
Mabs|April 4, 2022
In silico proof of principle of machine learning-based antibody design at unconstrained scaleRahmad Akbar, Philippe A Robert, Cédric R Weber, et al.
Biomedicines|September 23, 2022
<i>TLR5</i> Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell LineJurica Baranašić, Maja Šutić, Calogerina Catalano, et al.
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Annals of Hepatology|December 3, 2015
Hypothermia is better than ischemic preconditioning for preventing early hepatic ischemia/reperfusion in ratsLarisse Longo, Leila Xavier Sinigaglia-Fratta, Giovana R Weber, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Vaccines|September 28, 2023
CD4<sup>+</sup> T Cell Responses to <i>Toxoplasma gondii</i> Are a Double-Edged SwordKamal El Bissati, Paulette A Krishack, Ying Zhou, et al.
Pageof 122